{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-23-000063","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2023-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.192596+00:00","generated_at":"2026-06-09T13:54:59.235888+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teladoc Q3 revenue up 8% to $660.2M; adjusted EBITDA surges 73% to $88.8M","bullets":["Net loss narrowed to $57.1M ($0.35/sh) from $73.5M ($0.45/sh) a year ago; adjusted EBITDA $88.8M.","Integrated Care revenue +9% to $374.4M; BetterHelp revenue +8% to $285.8M.","Operating cash flow $105.6M, free cash flow $68.0M; strong cash generation.","Q4 guidance: rev $658-683M, adj EBITDA $107-117M; FY23 rev $2.60-2.625B, adj EBITDA $320-330M.","CEO announces comprehensive operational review to drive efficiency and improve business performance."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-23-000063","json":"https://secwatch.observer/filing/0001477449-23-000063.json","markdown":"https://secwatch.observer/filing/0001477449-23-000063.md","text":"https://secwatch.observer/filing/0001477449-23-000063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000063/0001477449-23-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000063/tdoc-20231024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T13:54:59.235888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"490ff2091061b9b6644dac1b31cb558308bd3c2a","claim":"Teladoc Health, Inc. reported the third quarter of 2023 results: revenue $660.2 million, net income $57.1 million, EPS $0.35 per share.","evidence_excerpt":"Teladoc Health Reports Third Quarter 2023 Results • Third quarter 2023 revenue grows 8% year-over-year to $660.2 million • Third quarter 2023 operating cash flow of $105.6 million; free cash flow of $68.0 million • Third quarter 2023 net loss of $57.1 million, or $0.35 per share • Third quarter 2023 adjusted EBITDA of $88.8 million, up 73% year-over-year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744923000063/0001477449-23-000063-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of 2023"},{"label":"Revenue","value":"$660.2 million"},{"label":"Net income","value":"$57.1 million"},{"label":"EPS","value":"$0.35 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}